Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited, chronic disease and is progressive in nature. The onset of cystic fibrosis typically occurs in early childhood or, rarely, at birth. The primary symptoms of cystic fibrosis include breathing difficulties, high salt content in the sweat, and secretion of abnormally viscous mucus. The principal indicators of cystic fibrosis in patients are pancreatic insufficiency, pancreatitis, chronic bronchitis, adolescent diabetes, male sterility, and very rarely liver cirrhosis or intestinal obstruction. The most usual forms of cystic fibrosis are those with respiratory complications, difficulties related to digestion, and anomalies in height and growth. The mortality and morbidity of a patient are dependent on the degree of bronchopulmonary involvement.
Browse Full Research Report With TOC on http://www.radiantinsights.com/research/global-cystic-fibrosis-therapeutics-market-2016-2020
Covered in this report
The report covers the present scenario and the growth prospects of the global cystic fibrosis therapeutics market for 2016-2020. The report has taken into consideration the revenue generated by the vendors in the PET packaging market for packaging of different goods.
The market is divided into the following segments based on geography:
Global Cystic Fibrosis Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
• F. Hoffmann-La Roche
• Gilead Sciences
• Vertex Pharmaceuticals
Request A Sample Copy Of This Report at: http://www.radiantinsights.com/research/global-cystic-fibrosis-therapeutics-market-2016-2020/request-sample
Other prominent vendors
• Advanced Inhalation Therapies (AIT)
• Alaxia SAS
• Alcresta Therapeutics
• Chiesi Farmaceutici
• Corbus Pharmaceuticals
• Cyclacel Pharmaceuticals
• Digestive Care
• Insmed Incorporated
• Nivalis Therapeutics
• Parion Sciences
• ProQR Therapeutics
• Protalix Biotherapeutics
• Proteostasis Therapeutics
• PTC Therapeutics
See More Reports of This Category by Radiant Insights: http://www.radiantinsights.com/catalog/healthcare
• Special regulatory designations for drugs
• For a full, detailed list, view our report
Explore Other Reports By Radiant Insights,Inc at
- GaN Radio Frequency Devices Market –
- Refrigerated Cabinet Market –
About Radiant Insight
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States